Skip to main content
NANOVEU LIMITED logo

NANOVEU LIMITED — Investor Relations & Filings

Ticker · NVU ISIN · AU0000024796 LEI · 5299003PDOQ5DPU98119 ASX Manufacturing
Open in API
Filings indexed 627 across all filing types
Latest filing 2023-12-03 Interim / Quarterly Rep…
Country AU Australia
Listing ASX NVU

About NANOVEU LIMITED

https://nanoveu.com/

Nanoveu Limited specializes in the development of advanced materials and digital imaging solutions through nanotechnology. The company’s product portfolio includes EyeFly3D, a specialized film and software platform that enables glasses-free 3D visualization on mobile devices. Its Nanoshield product line features antimicrobial coatings and films that utilize copper ions to eliminate pathogens on frequently touched surfaces. Furthermore, the company is advancing EyeFyx technology, which aims to provide vision correction for individuals with presbyopia by manipulating digital screen output. Nanoveu focuses on integrating proprietary thin-film coatings with sophisticated algorithms to enhance display functionality and provide protective surface treatments across various consumer and commercial applications.

Recent filings

Filing Released Lang Actions
Half Yearly Report and Accounts 25 pages 1.4MB
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Appendix 4D' and explicitly states it is a 'Half year report' for the period ended 30 June 2023. It contains detailed financial statements including consolidated profit or loss, comprehensive income, statements of financial position, cash flows, notes to the financial statements, directors' report, and an independent auditor's review report. The presence of comprehensive financial data and analysis for a half-year period clearly identifies this as an Interim / Quarterly Report. The document is about 15,000 characters long, indicating it is a full report rather than a brief announcement or certification. Therefore, the correct classification is 'IR' for Interim / Quarterly Report. H1 2023
2023-12-03 English
Quarterly Appendix 4C Cash Flow Report 5 pages 272.9KB
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Appendix 4C Quarterly cash flow report for entities subject to Listing Rule 4.7B' and contains detailed quarterly cash flow statements including operating, investing, and financing activities. It references the ASX Listing Rules and provides financial data for the quarter ended 30 September 2023. The content is a comprehensive financial report for a period shorter than a full fiscal year, containing actual financial statements and analysis. This matches the definition of an Interim / Quarterly Report (IR). The document is not merely an announcement or certification but includes substantive financial data and analysis for the quarter. Q3 2023
2023-12-03 English
Quarterly Activities Report 3 pages 1.4MB
Interim / Quarterly Report Classification · 95% confidence The document is titled 'Quarterly Activities Report and Appendix 4C for the Quarter ended 30 September 2023' and provides a detailed update on the company's operations, financial expenditures, and activities during the quarter. It includes financial data such as staff costs, administration costs, and payments to related parties, which are substantive financial details. The document is about a quarterly period and contains actual financial and operational information, not just an announcement or a certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR). Q3 2023
2023-12-03 English
US $223,000 EyeFly3D Purchase Orders Received & MOU Secured 4 pages 278.5KB
Capital/Financing Update Classification · 95% confidence The document is an ASX release dated 06 November 2023 from Nanoveu Limited announcing receipt of purchase orders totaling US$223,000 and a memorandum of understanding (MOU) with Rahum Nanotech Co. Ltd. The content focuses on business development, product rollout, and partnership details rather than financial results or regulatory filings. There are no financial statements, earnings data, or audit information presented. The document is a corporate announcement about capital inflow from purchase orders and a strategic partnership, which fits the category of Capital/Financing Update (CAP). The length (9177 characters) and detailed business update support this classification rather than a brief announcement or regulatory filing. Therefore, the document is best classified as a Capital/Financing Update (CAP).
2023-11-05 English
NVU US Solar Trial Demonstrates 25% Improvement 4 pages 614.8KB
Regulatory Filings Classification · 95% confidence The document is an ASX release dated 1 November 2023 from Nanoveu Limited announcing the results of a US solar trial demonstrating a >25% improvement in solar panel performance due to their Nanoshield Solar product. The content focuses on the trial results, potential market opportunities, test methodology, and company product descriptions. It is a corporate announcement of a product trial and its implications rather than a financial report, earnings release, or regulatory filing. The document is not a full financial report, audit, or management discussion, nor does it contain financial statements or detailed financial data. It is also not a call transcript, AGM material, or voting results. The document is a company news release about a product trial and business development update, which fits best under Regulatory Filings (RNS) as a general announcement that does not fit other specific categories.
2023-10-31 English
Response to ASX Query 6 pages 804.4KB
Director's Dealing Classification · 95% confidence The document is a letter from Nanoveu Limited responding to a query from ASX Limited regarding late lodgement of Appendix 3Y and 3Z notices, which are related to changes in directors' interests. The content focuses on compliance with listing rules about director disclosures and the administrative oversight causing the delay. There are no financial statements, earnings data, or management discussion of financial results. The document is a regulatory compliance response concerning director dealings and disclosures, not a financial report or announcement of financial results. It is not a report publication announcement since it contains substantive explanation and response to a regulatory query. The document fits best under 'Director's Dealing' (DIRS) as it deals with directors' interest notices and related compliance issues.
2023-08-03 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.